A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)

被引：2
|
作者：
Miura, S. [1 ]
Hsia, T. [2 ]
Hung, J. [3 ]
Jung, H. A. [4 ]
Shih, J. [5 ]
Park, C. [6 ,7 ]
Lee, S. H. [8 ]
Okamoto, T. [9 ]
Ahn, H. K. [10 ]
Lee, Y. C. [11 ]
Sato, Y. [12 ]
Lee, S. S. [13 ]
Mascaux, C. [14 ]
Daoud, H. [15 ]
Maerten, A. [15 ]
Popat, S. [16 ,17 ]
机构：
[1] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan
[2] China Med Univ, Dept Resp Therapy, Dept Internal Med, China Med Univ Hosp, Taichung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[5] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[6] Chonnam Natl Univ, Sch Med, Dept Internal Med, Hwasun, South Korea
[7] Hwasun Hosp, Hwasun, South Korea
[8] Kyung Hee Univ, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med,Med Ctr, Seoul, South Korea
[9] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[10] Gachon Univ, Gil Med Ctr, Div Med Oncol, Incheon, South Korea
[11] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Dept Internal Med,Chonbuk Natl Univ Hosp,Med Sch, Jeonju, South Korea
[12] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan
[13] Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea
[14] Strasbourg Univ, Strasbourg Univ Hosp, Dept Pulm, Strasbourg, France
[15] Boehringer Ingelheim Int Gmbh, Ingelheim, Germany
[16] Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England
[17] Inst Canc Res, London, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2021.08.531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P50.03
引用
收藏
页码：S1115 / S1116
页数：2
相关论文
共 50 条
  • [41] Longitudinal Monitoring of EGFR Mutations in Plasma of EGFR Mutant NSCLC Patients Treated with EGFR TKIs: Korean Lung Cancer Consortium
    Lee, Ji Yun
    Bai Yali
    Wei Xiumin
    Hyeon, Bak So
    Lee, Ho Yun
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Cho, Eun Kyung
    Kim, Hye Ryun
    Min, Young Joo
    Kim, Dong-Wan
    Park, Keunchil
    Qing, Xu
    Mao, Mao
    Ahn, Myung-Ju
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S358 - S358
  • [42] Real-World Data of Osimertinib in Patients with Metastatic EGFRm plus NSCLC who Progressed on First-Line EGFR TKIs
    Ma, J.
    Tan, S. H.
    Yin, D.
    Tran, A.
    Tan, D.
    Ang, M.
    Takano, A.
    Lim, K. H. T.
    Kanesvaran, R.
    Jain, A.
    Rajasekaran, T.
    Tan, E.
    Lim, D. W.
    Ng, Q. S.
    Tan, W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S627 - S628
  • [43] Real-World Management of Patients with EGFR Mutation-Positive NSCLC in the US
    Li, Y.
    Appius, A.
    Pattipaka, T.
    Feyereislova, A.
    Cassidy, A.
    Ganti, A. K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2216 - S2216
  • [44] Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)
    Cuppens, K.
    Lodewyckx, L.
    Demedts, I.
    Decoster, L.
    Colinet, B.
    Deschepper, K.
    Janssens, A.
    Pauwels, P.
    Galdermans, D.
    Pieters, T.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1117 - S1117
  • [45] Real-world EGFR testing patterns among US patients with advanced NSCLC
    Vanderpoel, Julie
    Pericone, Chris
    He, Jinghua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [46] EGFR-TKI as neoadjuvant treatment in patients with NSCLC with EGFR sensitive mutation: A retrospective real-world analysis
    Liu, Sangtian
    Liang, Wenhua
    He, Jianxing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Real-world evidence data for detection of EGFR mutations in cf-DNA from metastatic NSCLC patients
    Michelli, Maria
    Giannopoulou, Ioanna
    Roupou, Eirini
    Chatziandreou, Ilenia
    Prekete, Niki
    Kaparis, Theofilos
    Kavantzas, Nikolaos
    Saetta, Angelica A.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 260 - 261
  • [48] Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC (UNICORN): A phase 2 study
    Okuma, Yusuke
    Kubota, Kaoru
    Shimokawa, Mototsugu
    Hashimoto, Kana
    Kawashima, Yosuke
    Sakamoto, Tomohiro
    Wakui, Hiroshi
    Murakami, Shuji
    Okishio, Kyoichi
    Hayashihara, Kenji
    Ohe, Yuichiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] New data on clinical decisions in NSCLC patients with uncommon EGFR mutations
    Wu, Ting-Hui
    Hsiue, Emily Han-Chung
    Lee, Jih-Hsiang
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (01) : 51 - 55
  • [50] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    S. Chen
    J. Zhao
    L. Cui
    Y. Liu
    [J]. Clinical and Translational Oncology, 2017, 19 : 332 - 340
12345